Stockholm, November 14, 2023. Sigrid Therapeutics today announced that the company has launched Glucose Stabiliser…

Both Nordic and international investors were attracted by Sigrid’s natural, non-drug alternative SiPore® Stockholm, Sweden,…

World-renowned oral healthcare expert joins Sigrid’s SAB to investigate impact of the SiPore® technology on…

Sigrid Therapeutics unveils SiPore® to prevent oral pathogenic bacterial growth and plaque formation at International…

Produkten, som tas i form av kapsel eller gel förhindrar att en del av matsmältningsenzymerna…

“Molecular sieves” swallowed in capsules and gels reported safe, easy to digest and effective Stockholm,…

Sigrid Therapeutics tar in ytterligare 10,6 miljoner kronor i övertecknad företrädesemission för att påskynda kommersialiseringen…

Sigrid Therapeutics raises further SEK10.6 million in oversubscribed rights issue for accelerated SiPore® commercialization Swedish…

Sigrid Therapeutics utser Mattias Ankerberg, en internationell ledarprofil från konsumentvarubranschen till ordförande Företaget siktar mot…

Sigrid Therapeutics appoints internationally established consumer industry executive Mattias Ankarberg as Chairman Company aims to…